✦ LIBER ✦

No Influence of Ethnic Origin on the Pharmacokinetics and Pharmacodynamics of Melagatran Following Oral Administration of Ximelagatran, a Novel Oral Direct Thrombin Inhibitor, to Healthy Male Volunteers

✍ Scribed by Linda C. Johansson, Magnus Andersson, Gunnar Fager, David Gustafsson, Dr Ulf G. Eriksson

Book ID: 119926486
Publisher: Springer International Publishing AG
Year: 2003
Tongue: English
Weight: 156 KB
Volume: 42
Category: Article
ISSN: 0312-5963
DOI: 10.2165/00003088-200342050-00005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparable Pharmacokinetics and Pharmaco

Comparable Pharmacokinetics and Pharmacodynamics of Melagatran in Japanese and Caucasian Volunteers after Oral Administration of the Direct Thrombin Inhibitor Ximelagatran

✍ Dr Linda C. Wernevik, Per Nyström, Magnus Andersson, Gillis Johnsson, Anders Byl 📂 Article 📅 2006 🏛 Springer International Publishing AG 🌐 English ⚖ 213 KB

Pharmacokinetics and pharmacodynamics of

Pharmacokinetics and pharmacodynamics of ximelagatran, a novel oral direct thrombin inhibitor, in young healthy male subjects

✍ Ulf G. Eriksson; Ulf Bredberg; Kristina Gislén; Linda C. Johansson; Lars Frison; 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 291 KB

No Influence of Obesity on the Pharmacok

No Influence of Obesity on the Pharmacokinetics and Pharmacodynamics of Melagatran, the Active Form of the Oral Direct Thrombin Inhibitor Ximelagatran

✍ Dr Troy C. Sarich, Renli Teng, Gary R. Peters, Maria Wollbratt, Robert Homolka, 📂 Article 📅 2003 🏛 Springer International Publishing AG 🌐 English ⚖ 124 KB

No Influence of Mild-To-Moderate Hepatic

No Influence of Mild-To-Moderate Hepatic Impairment on the Pharmacokinetics and Pharmacodynamics of Ximelagatran, an Oral Direct Thrombin Inhibitor

✍ Dr Karin Wåhlander, Maria Eriksson-Lepkowska, Lars Frison… 📂 Article 📅 2003 🏛 Springer International Publishing AG 🌐 English ⚖ 131 KB

Influence of activated charcoal on the p

Influence of activated charcoal on the pharmacokinetics of moxifloxacin following intravenous and oral administration of a 400 mg single dose to healthy males

✍ H. Stass; D. Kubitza; J.-G. Möller; H. Delesen 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB